BENJAMIN STACY: Open Payments
NPI 1093127367 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 20 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $79 |
| Neurocrine BioSciences, Inc. | 3 | $77 |
| ABBVIE INC. | 3 | $64 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
| Alkermes, Inc. | 2 | $40 |
| Luye Pharma (USA) Ltd. | 1 | $26 |
| Lundbeck LLC | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: INGREZZA, VRAYLAR, COBENFY, Qelbree, AUSTEDO XR, ARISTADA, UZEDY, ERZOFRI EXTENDED-RELEASE.
Industry payments across NC — which companies pay providers there.
